What is the recommended prazosin dose for treating nightmares?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prazosin Dosing for Nightmares

Start prazosin at 1 mg at bedtime and titrate upward by 1-2 mg every few days based on nightmare response, targeting an average maintenance dose of 3-10 mg nightly for civilians and 10-16 mg for military veterans with combat-related PTSD, with a maximum of 20 mg at bedtime. 1

Initial Dosing Strategy

Begin with 1 mg at bedtime only to minimize the risk of first-dose syncope and orthostatic hypotension 1, 2. The FDA label explicitly warns that initial doses of 2 mg or greater carry approximately 1% risk of syncope, typically occurring 30-90 minutes after the first dose 2.

Titration Protocol

  • Increase by 1-2 mg every few days until nightmares resolve or diminish to an acceptable level 1
  • Monitor blood pressure after each dose increase, particularly checking for orthostatic changes
  • Most patients respond within weeks of reaching therapeutic dose 3

Target Maintenance Doses

The evidence shows clear population-based differences:

For Civilian Trauma/PTSD:

  • Average effective dose: 3-10 mg at bedtime 1
  • Range studied: 1-15 mg, with mean doses of 3.1 mg, 8.9 mg, and 9.5 mg across different trials 4, 1

For Military Veterans with Combat PTSD:

  • Average effective dose: 10-16 mg at bedtime 3, 5
  • Higher doses needed: Mean of 13-15.6 mg for men in military studies 4
  • Maximum: 20 mg at bedtime 4, 6

Sex-Based Dosing:

  • Men: Target 15-16 mg at bedtime 4, 5
  • Women: Target 7-10 mg at bedtime 4, 5

Split Dosing for Daytime Symptoms

If daytime flashbacks or breakthrough symptoms occur, consider adding a mid-morning dose 4, 5:

  • Men: 4-5 mg mid-morning
  • Women: 2 mg mid-morning
  • Some patients benefit from three-times-daily dosing given prazosin's 2-3 hour half-life 7

Critical Safety Considerations

Monitor for orthostatic hypotension at each dose increase—this is the most common adverse effect and can be dose-limiting 1, 2. Have patients:

  • Rise slowly from sitting/lying positions
  • Check blood pressure standing and supine
  • Report dizziness, lightheadedness, or falls immediately

Avoid situations where syncope could cause injury during initial titration 2.

Evidence Quality and Contradictions

The 2018 American Academy of Sleep Medicine position paper downgraded prazosin's recommendation after a large VA study (n=304) showed no benefit at mean dose of 14.8 mg 4. However, the guideline explicitly states that "many patients respond very well to prazosin and this agent remains the first choice for pharmacologic therapy" 4.

The key difference: 78% of patients in the negative VA study were on concurrent antidepressants, which may interfere with prazosin's efficacy 4. Earlier studies showed decreased prazosin response in patients taking SSRIs 4.

Clinical Algorithm

  1. Start 1 mg at bedtime (mandatory for safety) 1, 2
  2. Increase by 1-2 mg every 3-7 days based on nightmare frequency and tolerability 1
  3. Target 3-10 mg for civilians, 10-16 mg for military veterans 1, 3, 5
  4. Add mid-morning dose (2-5 mg) if daytime symptoms persist 5
  5. Maximum 20 mg at bedtime (rarely needed; doses above 20 mg show no additional benefit) 4, 2
  6. If on antidepressants: May need higher doses or consider alternative if no response 4

Common Pitfall

Do not use 2 mg or 5 mg capsules for initial therapy—the FDA label specifically states these are not indicated for initial dosing due to syncope risk 2. Always start with 1 mg capsules.

References

Guideline

best practice guide for the treatment of nightmare disorder in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Research

Prazosin in the treatment of PTSD.

Journal of psychiatric practice, 2014

Guideline

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.